Article Details

Morgan Stanley Trims Alnylam Pharmaceuticals (NASDAQ:ALNY) Target Price to $175.00

Retrieved on: 2023-10-10 00:03:10

Tags for this article:

Click the tags to see associated articles and topics

Morgan Stanley Trims Alnylam Pharmaceuticals (NASDAQ:ALNY) Target Price to $175.00. View article details on HISWAI: https://www.marketbeat.com/instant-alerts/nasdaq-alny-a-buy-or-sell-right-now-2023-10-09/

Excerpt

Morgan Stanley dropped their price objective on Alnylam Pharmaceuticals from $210.00 to $175.00 in a research note on Monday.

Article found on: www.marketbeat.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up